These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 18075629)

  • 1. Primary hyperparathyroidism and familial hyperparathyroid syndromes.
    Blackburn M; Diamond T
    Aust Fam Physician; 2007 Dec; 36(12):1029-33. PubMed ID: 18075629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic and hereditary primary hyperparathyroidism.
    Pepe J; Cipriani C; Pilotto R; De Lucia F; Castro C; Lenge L; Russo S; Guarnieri V; Scillitani A; Carnevale V; D'Erasmo E; Romagnoli E; Minisola S
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):40-4. PubMed ID: 21985979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid surgery in familial hyperparathyroid disorders.
    Carling T; Udelsman R
    J Intern Med; 2005 Jan; 257(1):27-37. PubMed ID: 15606374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hypercalcemia in relation to hyperparathyroidism.
    Pellitteri PK
    Otolaryngol Clin North Am; 2010 Apr; 43(2):389-97, x. PubMed ID: 20510722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
    Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
    Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary hyperparathyroidism].
    Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
    Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical therapy for familial hyperparathyroidism.
    Sharma J; Weber CJ
    Am Surg; 2009 Jul; 75(7):579-82; discussion 582-3. PubMed ID: 19655601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial benign hypercalcaemia. Study of a large family.
    Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
    Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome.
    Lew JI; Irvin GL
    Surgery; 2009 Dec; 146(6):1021-7. PubMed ID: 19879612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone-dependent hypercalcemia.
    Toke J; Patócs A; Balogh K; Gergics P; Stenczer B; Rácz K; Tóth M
    Wien Klin Wochenschr; 2009; 121(7-8):236-45. PubMed ID: 19562279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of patients with raised serum calcium level in primary care, Sweden.
    Dalemo S; Hjerpe P; Boström Bengtsson K
    Scand J Prim Health Care; 2006 Sep; 24(3):160-5. PubMed ID: 16923625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies.
    McGill J; Sturgeon C; Kaplan SP; Chiu B; Kaplan EL; Angelos P
    J Am Coll Surg; 2008 Aug; 207(2):246-9. PubMed ID: 18656054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary parameters as predictors of primary hyperparathyroidism in patients with nephrolithiasis.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    J Urol; 2012 Feb; 187(2):516-21. PubMed ID: 22177167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum gastrin level is increased by chronic hypercalcemia of parathyroid or nonparathyroid origin.
    Zaniewski M; Jordan PH; Yip B; Thornby JI; Mallette LE
    Arch Intern Med; 1986 Mar; 146(3):478-82. PubMed ID: 2869739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial isolated primary hyperparathyroidism--description and analyses of six cases].
    Moulin LX; Cantoni J; Baccarini Neto R; Corrêa PL; Mesquita CT; Figueiredo JG; Lima MB
    Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1544-50. PubMed ID: 18209900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
    Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with primary hyperparathyroidism--why do some form stones?
    Berger AD; Wu W; Eisner BH; Cooperberg MR; Duh QY; Stoller ML
    J Urol; 2009 May; 181(5):2141-5. PubMed ID: 19296981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.
    Brunaud L; Germain A; Zarnegar R; Rancier M; Alrasheedi S; Caillard C; Ayav A; Weryha G; Mirallie E; Bresler L
    Surgery; 2009 Dec; 146(6):1035-41. PubMed ID: 19958930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
    Raue F; Haag Ch; Frank-Raue K
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.